ClinicalTrials.govpublic full text
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
carcinoma of unknown primary, cup, pembrolizumab, keytruda, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900221
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.